-+ 0.00%
-+ 0.00%
-+ 0.00%

3 Penny Stocks To Own In September 2026

Simply Wall St·09/23/2026 03:27:58
语音播报

Rising interest rates after the latest Federal Reserve hike have made borrowing more expensive and pushed many investors toward stronger balance sheets. Cheaper stocks often carry fragile finances, which can magnify that pressure. That is where financially healthier, low-priced shares come in. This article walks through three carefully selected under-$5 opportunities that combine penny-level entry prices with a focus on keeping the books in better shape.

The three stocks in this article are only a small sample of what screens as financially fit under $5, with the full filter surfacing 315 more companies that pair low share prices with balance sheets that aim to keep risk under tighter control.

Head straight into the Financially Fit Penny Stocks screener to identify, filter, and analyze the penny stocks that best match your own conviction and risk appetite.

NIO (NIO)

NIO anchors this screener pick with a pure play on premium electric SUVs and sedans, backed by its own charging ecosystem and service offerings. Together, these give the business more than just car sales to lean on as it works toward stronger financial footing.

NIO generates all of its CN¥114,113 million revenue from smart electric vehicles and related services, primarily in China, and carries a market value of about US$9.2b.

"Expansion and densification of NIO's proprietary Power Swap network and charging infrastructure across China's largest cities and highways removes range anxiety and further differentiates NIO from competitors, accelerating EV adoption and increasing recurring services revenue and margin stability."

What really matters now is how one still unresolved pressure point shapes the balance between that services engine and future profitability.

That unresolved pressure point is exactly what the full narrative for NIO unpacks, separating short term strain from what could be accelerating long run operating leverage for NIO.

NYSE:NIO Earnings & Revenue Growth as at Sep 2026
NYSE:NIO Earnings & Revenue Growth as at Sep 2026

Grab Holdings (GRAB)

Grab Holdings runs a Southeast Asian superapp that ties together ride-hailing, deliveries, advertising and GrabFin, its financial services arm that fits the Financially Fit Penny Stocks theme by focusing on credit and payments while keeping a close eye on lending risk.

Grab earns most of its US$3.7b turnover from Deliveries at US$2.0b and Mobility at US$1.3b, with Financial Services contributing US$430 million and a small US$4 million from Others, and the stock carries a market value of about US$12.9b.

"The $307 million remeasurement is interesting accounting history. The $19 million operating profit is investment information."

The outcome over the next few quarters, whether that operating progress results in steadier cash generation or reveals its limitations, will be significant.

That turning point is exactly what the full narrative for Grab Holdings unpacks, showing where operating progress could be accelerating, where risks may be masking upside, and how the story might evolve next.

NasdaqGS:GRAB Revenue & Expenses Breakdown as at Sep 2026
NasdaqGS:GRAB Revenue & Expenses Breakdown as at Sep 2026

Clover Health Investments (CLOV)

Clover Health Investments focuses on Medicare Advantage plans for US seniors, which ties it directly to the Financially Fit Penny Stocks theme by offering a recurring, regulated insurance product rather than optional add ons.

Clover Health Investments generates about US$2.5b from Insurance in the United States and has a market value of roughly US$2.4b.

Clover Health Investments brings the Financially Fit Penny Stocks idea into healthcare through its Medicare Advantage plans, backed by the Clover Assistant software that aims to keep medical costs under tighter control while the business works on improving profitability and capital discipline.

"Clover Health Investments disclosed prior knowledge of a Department of Justice inquiry and announced a separate Securities and Exchange Commission inquiry related to potential securities fraud tied to its Medicare plans, following allegations from Hindenburg Research."

The real swing factor now is how a single pressure point on future economics plays out across margins and expectations for the business.

How that pressure point reshapes Clover Health Investments' future economics is exactly what the full narrative for Clover Health Investments unpacks. It highlights where risk could be masking accelerating upside.

NasdaqGS:CLOV Revenue & Expenses Breakdown as at Sep 2026
NasdaqGS:CLOV Revenue & Expenses Breakdown as at Sep 2026

Seeking Fresh Alternatives Before They Fly

Fresh opportunities move quickly. Breakout stories gain momentum, then the best entry points get caught by the crowd and drop away. Scan these ideas while it matters and get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.